The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel Syndrome
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Small-intestinal bacterial overgrowth (SIBO) is a frequent finding in patients with irritable bowel syndrome (IBS). Many patients with IBS also have abnormal intestinal permeability, which is probably due to low-grade inflammation in the intestinal mucosa. Our aim was to verify the relationship between SIBO and small-intestinal permeability in IBS patients. Methods: A cohort of 38 IBS patients (20 women and 18 men; age range 16-70 years; mean age 40.2 years) with symptoms that fulfilled Rome-II criteria, and 12 healthy controls (5 women and 7 men; age range 25-52 years; mean age: 37.8 years) were recruited. All subjects underwent lactulose breath tests (LBTs) and intestinal permeability tests using the polyethylene glycol (PEG) 3350/400 retrieval ratio. Results: A positive LBT was found in 18.4% (7/38) of patients with IBS and 8.3% (1/12) of control subjects. Intestinal permeability was significantly increased in patients with IBS compared with the normal controls (0.82±0.09 vs 0.41±0.05 [mean±SD], respectively; p<0.05). However, the intestinal permeability did not differ significantly between IBS patients with a positive LBT and those with a negative LBT (0.90±0.13 and 0.80±0.11, respectively; p>0.05). Conclusions: Intestinal permeability was increased in patients with IBS, but this finding did not correlated with the occurrence of SIBO.
Abstract
Background/Aims: Small-intestinal bacterial overgrowth (SIBO) is a frequent finding in patients with irritable bowel syndrome (IBS). Many patients with IBS also have abnormal intestinal permeability, which is probably due to low-grade inflammation in the intestinal mucosa. Our aim was to verify the relationship between SIBO and small-intestinal permeability in IBS patients. Methods: A cohort of 38 IBS patients (20 women and 18 men; age range 16-70 years; mean age 40.2 years) with symptoms that fulfilled Rome-II criteria, and 12 healthy controls (5 women and 7 men; age range 25-52 years; mean age: 37.8 years) were recruited. All subjects underwent lactulose breath tests (LBTs) and intestinal permeability tests using the polyethylene glycol (PEG) 3350/400 retrieval ratio. Results: A positive LBT was found in 18.4% (7/38) of patients with IBS and 8.3% (1/12) of control subjects. Intestinal permeability was significantly increased in patients with IBS compared with the normal controls (0.82±0.09 vs 0.41±0.05 [mean±SD], respectively; p<0.05). However, the intestinal permeability did not differ significantly between IBS patients with a positive LBT and those with a negative LBT (0.90±0.13 and 0.80±0.11, respectively; p>0.05). Conclusions: Intestinal permeability was increased in patients with IBS, but this finding did not correlated with the occurrence of SIBO.
참고문헌 (34)
- Lin HC, "Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome", JAMA, 292, pp.852~858 (2004)
- Pimentel M, "Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo- controlled study", Am J Gastroenterol, 98, pp.412~419 (2003)
- Posserud I, "Small intestinal bacterial overgrowth in patients with irritable bowel syndrome", Gut, 56, pp.802~808 (2007)
- Lupascu A, "Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome", Aliment Pharmacol Ther, 22, pp.1157~1160 (2005)
- Walters B, "Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls", Am J Gastroenterol, 100, pp.1566~1570 (2005)
- Pimentel M, "Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome", Am J Gastroenterol, 95, pp.3503~3506 (2000)
- Kyoung Sup Hong, "Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome", Gut and Liver, 3(2), pp.101~107 (2009), 거트앤리버 발행위원회
- Berg RD, "Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model", Infect Immun, 23, pp.403~411 (1979)
- Woodcock NP, "Bacterial translocation and immunohistochemical measurement of gut immune function", J Clin Pathol, 54, pp.619~623 (2001)
- Nieuwenhuijs VB, "The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats", Ann Surg, 228, pp.188~193 (1998)
- Weston AP, "Terminal ileal mucosal mast cells in irritable bowel syndrome", Dig Dis Sci, 38, pp.1590~1595 (1993)
- O'Sullivan M, "Increased mast cells in the irritable bowel syndrome", Neurogastroenterol Motil, 12, pp.449~457 (2000)
- Gwee KA, "The role of psychological and biological factors in postinfective gut dysfunction", Gut, 44, pp.400~406 (1999)
- Salzmann JL, "Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases", Lab Invest, 60, pp.847~551 (1989)
- O'Mahony L, "Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles", Gastroenter ology, 128, pp.541~551 (2005)
- Khaldun Al-Khatib, "Immune Activation and Gut Microbes in Irritable Bowel Syndrome", Gut and Liver, 3(1), pp.14~19 (2009), 거트앤리버 발행위원회
- EDTA in children with acute gastroenteritis or eczema, "J Pediatr Gastroenterol Nutr", 1985, 393~396
- Bjarnson I, "Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease", Gastroenterology, 85, pp.318~322 (1983)
- Dunlop SP, "Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes", Am J Gastroenterol, 101, pp.1288~1294 (2006)
- Tibble JA, "Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease", Gastroenterology, 123, pp.450~460 (2002)
- Dainese R, "Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients", Am J Gastroenterol, 94, pp.1892~1897 (1999)
- American Gastroenterology Association, "American Gastroenterological Association medical position statement: irritable bowel syndrome", Gastroenterology, 123, pp.2105~2107 (2002)
- Spiller RC, "Postinfectious irritable bowel syndrome", Gastroenterology, 124, pp.1662~1671 (2003)
- Beck A, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
- Spielberger C, "Manual for the state-trait anxiety inventory" (1983), Consulting Psychologists Press
- Peled Y, "Factors affecting methane production in humans: gastrointestinal diseases and alterations of colonic flora", Dig Dis Sci, 32, pp.267~271 (1987)
- DiPalma JA, "Comparison of colon cleansing methods in preparation for colonoscopy", Gastroenterology, 86, pp.856~860 (1984)
- Schiller LR, "Validation of polyethylene glycol 3350 as a poorly absorbable marker for intestinal perfusion studies", Dig Dis Sci, 42, pp.1~5 (1997)
- Winne D, "Appearance of 14C-polyethylene glycol 4000 in intestinal venous blood: influence of osmolarity and laxatives, effect on net water flux determination", Naunyn Schmiedebergs Arch Pharmacol, 321, pp.149~156 (1982)
- Ameno H, "New method for the detection of bacterial translocation using intestinal permeability with polyethylene glycol 4000", Eur Surg Res, 32, pp.23~29 (2000)
- Loret S, "Analysis of PEG 400 and 4000 in urine for gut permeability assessment using solid phase extraction and gel permeation chromatography with refractometric detection", J Chromatogr B Analyt Technol Biomed Life Sci, 805통권 : 1, pp.195~202 (2004)
- Bjarnason I, "Intestinal permeability: an overview", Gastroenterology, 108, pp.1566~1581 (1995)
- Chadwick VS, "Activation of the mucosal immune system in irritable bowel syndrome", Gastroenterology, 122, pp.1778~1783 (2002)
- Jacob C, "Mast cell tryptase controls paracellular permeability of the intestine: role of protease-activated receptor 2 and beta-arrestins", J Biol Chem, 280, pp.31936~31948 (2005)
